Wyeth's Preventative Osteoporosis Treatment Gets Approvable Letter

Washington Drug Letter
KEYWORDS DrugApprovals / FDA
A A
The FDA sent Wyeth an approvable letter for its postmenopausal osteoporosis prevention product, bazedoxifene, April 24.

To View This Article:

Login